Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy.

Sigsgaard, T

Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy. [electronic resource] - British journal of cancer May 1999 - 412-8 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0007-0920

10.1038/sj.bjc.6690372 doi


Adult
Aged
Antiemetics--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--complications
Cyclophosphamide--administration & dosage
Dopamine Antagonists--adverse effects
Double-Blind Method
Drug Administration Schedule
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Glucocorticoids--adverse effects
Granisetron--adverse effects
Humans
Isonipecotic Acids--adverse effects
Methotrexate--administration & dosage
Middle Aged
Nausea--chemically induced
Prednisolone--adverse effects
Serotonin Antagonists--adverse effects
Vomiting--chemically induced